)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Galectin Therapeutics
Galectin Therapeutics (GALT) investor relations material
Galectin Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary13 Oct, 2026
Executive summary
Annual meeting scheduled for Dec. 3, 2026, at 11:00 a.m. EST, virtually; voting deadline is Dec. 2, 2026, at 11:59 p.m. ET.
Voting matters and shareholder proposals
Shareholders will vote on 11 director nominees, an increase in authorized common shares, an equity plan share reserve increase, and auditor ratification; the board recommends For each proposal.
Proposal 3 seeks approval to add 3,000,000 shares to the 2019 Omnibus Equity Incentive Plan reserve.
Board of directors and corporate governance
Eleven director nominees: Gilbert F. Amelio, Henry Brem, Benjamin S. Carson Sr., Kary Eldred, Kevin D. Freeman, Joel Lewis, Gilbert S. Omenn, Elissa J. Schwartz, Harold H. Shlevin, Richard E. Uihlein, and Richard A. Zordani.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Galectin Therapeutics
- Share expansion and equity-plan votes accompany a major related-party debt-to-equity conversion.GALT
Proxy filing - Votes seek 100M more authorized shares and 3M additional equity-plan shares.GALTProxy filing
- Belapectin 2 mg reduced new varices and improved biomarkers, advancing to phase III trials.GALTH.C. Wainwright 28th Annual Global Investment Conference
- NAVIGATE trial supports belapectin's efficacy; FDA-aligned Phase 3 and major debt converted to equity.GALTQ2 2026
- Q1 2026 net loss improved to $5.0M as belapectin showed efficacy in MASH cirrhosis; cash runway to May 2027.GALTQ1 2026
- Biotech seeks up to $200M for NASH therapy, with $32.5M at-the-market stock offering.GALTRegistration filing
- Belapectin program advances with strong clinical data, improved financials, and extended cash runway.GALTQ4 2025
- Belapectin reduced new varices in MASH cirrhosis and showed promise in cancer therapy.GALTCorporate presentation
- Belapectin reduced new varices and improved fibrosis biomarkers in advanced MASH cirrhosis.GALTKOL event
Next Galectin Therapeutics earnings date
Q3 202613 Nov, 2026
Galectin Therapeutics
Next Galectin Therapeutics earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage